0001950047-25-005455.txt : 20250805 0001950047-25-005455.hdr.sgml : 20250805 20250805164020 ACCESSION NUMBER: 0001950047-25-005455 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250805 DATE AS OF CHANGE: 20250805 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 251185636 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Donoghoe Nicholas CENTRAL INDEX KEY: 0001762951 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 144 1 primary_doc.xml 144 0001762951 XXXXXXXX LIVE 0001551152 ABBVIE INC. 001-35565 1 North Waukegan Road North Chicago IL 60064-6400 847-932-7900 NICHOLAS DONOGHOE Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

13299 2639966.10 1766558253 08/05/2025 NYSE Common 11/15/2024 Dividend Reinvestment Shares Issuer N 535 11/15/2024 Cash Common 05/15/2024 Dividend Reinvestment Shares Issuer N 557 05/15/2024 Cash Common 02/28/2025 Performance Shares Issuer N 10061 02/28/2025 Not Applicable Common 02/15/2024 Dividend Reinvestment Shares Issuer N 510 02/15/2024 Cash Common 02/14/2025 Dividend Reinvestment Shares Issuer N 502 02/14/2025 Cash Common 08/15/2024 Dividend Reinvestment Shares Issuer N 469 08/15/2024 Cash Common 05/15/2025 Dividend Reinvestment Shares Issuer N 665 05/15/2025 Cash Y 08/05/2025 /s/ Nicholas Jason Donoghoe